Company’s 36-month beta value is 1.51.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CDNA is 48.65M, and currently, short sellers hold a 9.65% ratio of that float. The average trading volume of CDNA on May 01, 2024 was 791.33K shares.
CDNA) stock’s latest price update
Caredx Inc (NASDAQ: CDNA)’s stock price has gone rise by 16.21 in comparison to its previous close of 7.76, however, the company has experienced a 13.01% increase in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-18 that CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CDNA’s Market Performance
CDNA’s stock has risen by 13.01% in the past week, with a monthly drop of -9.37% and a quarterly rise of 5.35%. The volatility ratio for the week is 6.53% while the volatility levels for the last 30 days are 5.37% for Caredx Inc The simple moving average for the past 20 days is 4.83% for CDNA’s stock, with a -0.62% simple moving average for the past 200 days.
Analysts’ Opinion of CDNA
Stephens, on the other hand, stated in their research note that they expect to see CDNA reach a price target of $10. The rating they have provided for CDNA stocks is “Overweight” according to the report published on November 09th, 2023.
Raymond James gave a rating of “Outperform” to CDNA, setting the target price at $12 in the report published on August 15th of the previous year.
CDNA Trading at -5.64% from the 50-Day Moving Average
After a stumble in the market that brought CDNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.26% of loss for the given period.
Volatility was left at 5.37%, however, over the last 30 days, the volatility rate increased by 6.53%, as shares sank -9.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.81% upper at present.
During the last 5 trading sessions, CDNA rose by +14.29%, which changed the moving average for the period of 200-days by -9.88% in comparison to the 20-day moving average, which settled at $8.56. In addition, Caredx Inc saw -24.85% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDNA starting from Seeto Reginald, who sale 2,818 shares at the price of $6.91 back on Oct 02 ’23. After this action, Seeto Reginald now owns 479,164 shares of Caredx Inc, valued at $19,483 using the latest closing price.
Seeto Reginald sale 2,819 shares at $9.49 during a trade that took place back on Sep 05 ’23, which means that Seeto Reginald is holding 481,982 shares at $26,762 based on the most recent closing price.
Stock Fundamentals for CDNA
Current profitability levels for the company are sitting at:
- -0.37 for the present operating margin
- 0.63 for the gross margin
The net margin for Caredx Inc stands at -0.68. The total capital return value is set at -0.26. Equity return is now at value -54.98, with -36.40 for asset returns.
Based on Caredx Inc (CDNA), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -0.54. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is 231.92.
Currently, EBITDA for the company is -82.08 million with net debt to EBITDA at 0.53. When we switch over and look at the enterprise to sales, we see a ratio of 1.48. The receivables turnover for the company is 5.49for trailing twelve months and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.02.
Conclusion
In a nutshell, Caredx Inc (CDNA) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
